Paul-Ehrlich-Institut

The Paul-Ehrlich-Institut is the Federal Institute for Vaccines and Biomedicines, a senior federal authority in Germany that assesses and monitors the benefit-risk balance of biomedicines for human use and immunological medicines for veterinary use. It reports to the German Federal Ministry of Health and is responsible for the approval and monitoring of the quality, efficacy, and safety of medicines, including vaccines, allergens, antibodies, ATMPs, blood products, and veterinary medicines.

The institute is responsible for the approval of in-vitro diagnostics (IVD), the regulation of clinical trials, and pharmacovigilance. It also handles haemovigilance and tissue vigillance, as well as the approval of stem cell preparations and tissue preparations.

The site serves as a resource for professionals, patients, and the general public seeking authoritative data on biopharmaceuticals. It provides information on tasks, organization, and regulatory activities regarding human and veterinary medicines, blood products, and gene therapies.

Reviewers consistently highlight the professionalism and helpfulness of the staff, noting that they are knowledgeable and always ready to assist. Additionally, the website is frequently praised for its usability, navigation, and user-friendly nature.

There are 9 reviews on Trustburn with an average rating of 3.8 stars. The newest review is from November 2023, and the oldest is from December 2022, meaning none were posted in the last 12 months. The rating split consists of 3 five-star reviews, 2 four-star reviews, and 4 three-star reviews.

The website states that the PEI works internationally in the approval and supervision of the quality, efficacy, and safety of medicines. It also mentions that health knows no national borders, leading to international collaboration among experts.

People searching for this institute often use terms like 'paul ehrlich institut', 'pei germany', 'paul ehrlich institut langen', and 'bundesinstitut für impfstoffe und biomedizinische arzneimittel'. They also search for 'rezensionen für paul-ehrlich institut' to find reviews.

The institute is located in Langen, Hesse, Germany. It is also associated with Frankfurt in search queries, though its primary address is in Langen.

Reviewers mention that the staff is highly professional, friendly, and knowledgeable. They also note that the website is easy to navigate and provides all necessary information, making it a go-to company for their needs.

The institute is active in many important institutions and committees in Europe and worldwide, collaborating with organizations like the European Medicines Agency (EMA) and the World Health Organization (WHO).

The institute handles the approval of vaccines, allergens, antibodies, ATMPs, blood products, and veterinary medicines. It also covers in-vitro diagnostics and the regulation of clinical trials.

The institute provides a dedicated section for reporting side effects ('Nebenwirkungen melden') and handles pharmacovigilance, which includes monitoring the safety of medicines after they are on the market.

The website offers a newsroom, press releases, and a glossary. It also includes sections for career opportunities, newsletters, and legal information, along with a cookie consent notice for statistical data collection.

The FAQ section covers topics such as drug approval, clinical trials, batch testing, drug safety, and vaccines. It also includes specific questions about allergens, antibodies, ATMPs, blood products, and veterinary medicines.

The institute operates under principles that emphasize safety, efficacy, and quality. It also focuses on international cooperation and the idea that health knows no national borders.